Professor Gus Gazzard and the team delivering the LiGHT trial have won an award from the International Glaucoma Association (IGA) for excellence in glaucoma care.
The team was nominated for the award by a patient who was treated as part of the LiGHT trial. The patient described their positive experience being part of this trial and was very impressed with the care they received from Gus and his team.
The IGA award for excellence in glaucoma care recognises clinical proficiency, teamwork, compassion and commitment of glaucoma clinicians.
The LiGHT trial evaluated whether using a laser-based treatment on newly diagnosed cases of glaucoma was more successful and cost-effective than the current method of using pressure lowering eye drops. It was found that the laser-based treatment had better outcomes for patients and could save the NHS a significant amount of money.
Gus Gazzard, UCL Professor of Ophthalmology and Director of the Moorfields Glaucoma Service, said: “I am delighted that the LiGHT trial team has been recognised as providing excellent glaucoma care, which is set to change the way glaucoma is treated in future. It is particularly special that the nomination for this award has come from a patient, as improving the lives of our patients is always our goal.”
Learn more about the LiGHT trial.
Was this information useful? Please rate the page.